Literature DB >> 20061702

Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.

Kais Harzallah1, Raoudha Belhadj, Boutheina Jemli, Mondher Haloues, Naoufel Berraies, Saadia Gargouri, Jalel Hmida, Riadh Battikh, Jamel Manaa.   

Abstract

Leishmaniasis is an infection caused by a protozoan parasite belonging to the genus Leishmania and transmitted by the Phlebotomus sandfly. We report a case of visceral leishmaniasis in a 49-year-old male renal transplant recipient, a resident of the western part of Tunisia, which is an endemic zone for the disease. Just before and after the transplantation, the patient resided in Tunis, which is non-endemic for leishmaniasis. Visceral leishmaniasis occurred eight years after renal transplantation, and the clinical picture was characterized by fever and pancytopenia. Leishmaniae were detected by bone marrow aspiration. Pentavalent antimonal was used for 28 days and was substituted by allopurinol (20 mg/kg per day). One year after the infection, the patient remains totally asymptomatic. Our report suggests that visceral leishmaniasis may complicate the clinical course of organ transplantation and can be fatal, particularly when untreated. Relapses may occur after completion of the apparently effective treatment. Allopurinol could be a solution to avoid these relapses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061702

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  3 in total

1.  Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole.

Authors:  Soumaya Yaich; Khaled Charfeddine; Abderrahmen Masmoudi; Mondher Masmoudi; Sawssen Zaghdhane; Hamida Turki; Jamil Hachicha
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526

2.  Allopurinol reduces antigen-specific and polyclonal activation of human T cells.

Authors:  Damián Pérez-Mazliah; María C Albareda; María G Alvarez; Bruno Lococo; Graciela L Bertocchi; Marcos Petti; Rodolfo J Viotti; Susana A Laucella
Journal:  Front Immunol       Date:  2012-09-21       Impact factor: 7.561

Review 3.  New insights into leishmaniasis in the immunosuppressed.

Authors:  Hannah Akuffo; Carlos Costa; Johan van Griensven; Sakib Burza; Javier Moreno; Mercè Herrero
Journal:  PLoS Negl Trop Dis       Date:  2018-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.